sj-docx-1-tam-10.1177_17588359241229432 – Supplemental material for Prognosis of patients with residual pathological disease after neoadjuvant docetaxel, cisplatin, and 5-fluorouracil therapy and surgery for esophageal squamous cell carcinoma: a retrospective cohort study

Okunaka, Mashiro; Kotani, Daisuke; Fujiwara, Hisashi; Sato, Kazuma; Fujiwara, Naoto; Mishima, Saori; Sakashita, Shingo; Yoshino, Takayuki; Fujita, Takeo; Kojima, Takashi

doi:10.25384/SAGE.25283561.v1

sj-docx-1-tam-10.1177_17588359241229432.docx (145.52 kB)

sj-docx-1-tam-10.1177_17588359241229432 – Supplemental material for Prognosis of patients with residual pathological disease after neoadjuvant docetaxel, cisplatin, and 5-fluorouracil therapy and surgery for esophageal squamous cell carcinoma: a retrospective cohort study

journal contribution

posted on 2024-02-24, 13:10 authored by Mashiro Okunaka, Daisuke Kotani, Hisashi Fujiwara, Kazuma Sato, Naoto Fujiwara, Saori Mishima, Shingo Sakashita, Takayuki Yoshino, Takeo Fujita, Takashi Kojima

Supplemental material, sj-docx-1-tam-10.1177_17588359241229432 for Prognosis of patients with residual pathological disease after neoadjuvant docetaxel, cisplatin, and 5-fluorouracil therapy and surgery for esophageal squamous cell carcinoma: a retrospective cohort study by Mashiro Okunaka, Daisuke Kotani, Hisashi Fujiwara, Kazuma Sato, Naoto Fujiwara, Saori Mishima, Shingo Sakashita, Takayuki Yoshino, Takeo Fujita and Takashi Kojima in Therapeutic Advances in Medical Oncology